• English
    • español
    • português (Brasil)
  • português (Brasil) 
    • English
    • español
    • português (Brasil)
  • Entrar
Ver item 
  •   COVID-19
  • Resources in English
  • Technical documents and research evidence on COVID-19
  • Ver item
  •   COVID-19
  • Resources in English
  • Technical documents and research evidence on COVID-19
  • Ver item
JavaScript is disabled for your browser. Some features of this site may not work without it.

The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis

 
Thumbnail
Data
2020-03-31
Autor
Yang, Zhenwei et al.
Metadata
Mostrar registro completo
Resumo
Objectives: An outbreak of novel coronavirus in 2019 threatens the health of people, and there is no proven pharmacological treatment. Although corticosteroids were widely used during outbreaks of se- vere acute respiratory syndrome and Middle East respiratory syndrome, their efficacy remainedhighly controversial. We aimed to further evaluate the influence of corticosteroids on patients with coronavirus infection. Methods: We conducted a comprehensive search of literature published in PubMed, Embase, Cochrane library, and China National Knowledge Infrastructure (CNKI) from January 1, 2002 to March 15, 2020. All statistical analyses in this study were performed on stata14.0. Results: A total of 5270 patients from 15 studies were included in this meta-analysis. The result in- dicated that critical patients were more likely to require corticosteroids therapy (risk ratio [RR]=1.56, 95% confidence interval [CI] = 1.28-1.90, P<0.001). However, corticosteroid treatment was associated with higher mortality (RR=2.11, 95%CI=1.13-3.94, P=0.019), longer length of stay (weighted mean difference [WMD] = 6.31, 95%CI = 5.26–7.37, P<0.001), a higher rate of bacterial infection (RR = 2.08, 95%CI = 1.54–2.81, P<0.001), and hypokalemia (RR = 2.21, 95%CI = 1.07–4.55, P = 0.032) but not hy- perglycemia (RR = 1.37, 95%CI=0.68–2.76, P = 0.376) or hypocalcemia (RR = 1.35, 95%CI = 0.77–2.37, P = 0.302). Conclusions: Patients with severe conditions are more likely to require corticosteroids. Corticosteroid use is associated with increased mortality in patients with coronavirus pneumonia.
URI
https://doi.org/10.1016/j.jinf.2020.03.062
Collections
  • Technical documents and research evidence on COVID-19

Navegar

Todo o repositórioComunidades e ColeçõesPor data do documentoAutoresTítulosCategoriaAssuntosEsta coleçãoPor data do documentoAutoresTítulosCategoriaAssuntos

Minha conta

EntrarCadastro

Organização Pan-Americana da Saúde
Organização Mundial da Saúde. Escritório Regional para as Américas.
525 Twenty-third Street, N.W., Washington, D.C. 20037, Estados Unidos

Notas importantes sobre el contenido (Disclaimer)

Links

  • OPAS Doença por Coronavírus ‎‎(COVID-19)‎
  • OPAS/BIREME Vitrines do Conhecimento COVID-19

  • Biblioteca Digital da OPAS (IRIS PAHO)
  • Biblioteca Virtual em Saúde (BVS)
  • Global Index Medicus (GIM)